Print Friendly, PDF & Email

The Wall Street Journal blog reports on a new survey of US physicians that found the number who are “rep-accessible”, or willing to meet with drug company sales rep.s in the office, is down 18% from last year. However, still 58% of doctors take meetings with at least 70% of the reps who call and only 9% see fewer than 30% of calling salespeople. Drug companies have significantly reduced their sales forces in recent years. By 2012 it is expected that the number of drug reps will be down to 70,000; that is still one for every ten practicing US physicians.
Ellen Andrews